Silence Therapeutics Plc ADR (SLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -45,309 | -57,611 | -22,067 | -2,312 | -54,228 |
| Depreciation Amortization | 593 | 453 | 302 | 152 | 621 |
| Accounts receivable | -904 | N/A | -2,043 | -10,012 | 392 |
| Accounts payable and accrued liabilities | 499 | 2,187 | 3,003 | -2,849 | -473 |
| Other Working Capital | -33,023 | -2,000 | 610 | -10,323 | -15,244 |
| Other Operating Activity | 10,504 | 16,812 | 5,643 | 16,201 | 19,470 |
| Operating Cash Flow | $-67,640 | $-40,159 | $-14,552 | $-9,143 | $-49,462 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | -49,908 | 45,121 |
| PPE Investments | -211 | -149 | -85 | N/A | -56 |
| Purchase Of Investment | -139,167 | N/A | -49,866 | N/A | -25,771 |
| Other Investing Activity | 117,412 | -87,942 | 0 | 0 | 0 |
| Investing Cash Flow | $-21,966 | $-88,091 | $-49,951 | $-49,908 | $19,294 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 142,087 | 142,185 | 134,213 | 133,020 | 31,937 |
| Financing Cash Flow | $142,087 | $142,185 | $134,213 | $133,020 | $31,937 |
| Exchange Rate Effect | 60 | 219 | -49 | -35 | 749 |
| Beginning Cash Position | 68,789 | 68,789 | 68,789 | 68,789 | 66,271 |
| End Cash Position | 121,330 | 82,943 | 138,450 | 142,723 | 68,789 |
| Net Cash Flow | $52,541 | $14,154 | $69,661 | $73,934 | $2,518 |
| Free Cash Flow | |||||
| Operating Cash Flow | -67,640 | -40,159 | -14,552 | -9,143 | -49,462 |
| Capital Expenditure | -211 | -149 | -85 | N/A | -56 |
| Free Cash Flow | -67,851 | -40,308 | -14,637 | -9,143 | -49,518 |